Medicortex Finland

Turku, Finland Founded: 2014 • Age: 12 yrs
Diagnostic and treatment tools for neurodegenerative conditions are developed.

About Medicortex Finland

Medicortex Finland is a company based in Turku (Finland) founded in 2014.. Medicortex Finland has raised $581.79 thousand across 5 funding rounds from investors including European Union, Business Finland and Dividend Sweden. Medicortex Finland offers products and services including TBI Diagnostic Kit and Biomarker R&D Program. Medicortex Finland operates in a competitive market with competitors including Banyan Biomarkers, NeuroChaos Solutions, Saccadous, Silver Medical and GLIA Diagnostics, among others.

  • Headquarter Turku, Finland
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Medicortex Finland Oyj
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $581.79 K (USD)

    in 5 rounds

  • Latest Funding Round
    $581.79 K (USD), Seed

    Aug 09, 2021

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Medicortex Finland

Medicortex Finland offers a comprehensive portfolio of products and services, including TBI Diagnostic Kit and Biomarker R&D Program. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Tool for detecting and assessing Traumatic Brain Injury severity.

Develops biomarkers for Traumatic Brain Injury diagnosis.

People of Medicortex Finland
Headcount 1-10
Employee Profiles 3
Board Members and Advisors 1
Employee Profiles
People
Adrian Harel
CEO
People
Lasse Välimaa
Chief Scientific Officer
People
Pihla Miettinen
Chief Operating Officer

Unlock access to complete

Board Members and Advisors
people
Anna Tenstam
Board Member

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of Medicortex Finland

Medicortex Finland has successfully raised a total of $581.79K across 5 strategic funding rounds. The most recent funding activity was a Seed round of $581.79 thousand completed in August 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round Seed — $581,786
  • First Round

    (18 Feb 2016)

  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2021 Amount Seed - Medicortex Finland Valuation Dividend Sweden
Mar, 2021 Amount Grant - Medicortex Finland Valuation

investors

Feb, 2019 Amount Grant - Medicortex Finland Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Medicortex Finland

Medicortex Finland has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Business Finland and Dividend Sweden. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Government agency and accelerator focusing on innovative startups and SMEs
Founded Year Domain Location
Working capital loans are provided to businesses by Dividend Sweden.
Founded Year Domain Location
Innovation, internationalization, and investment support for businesses is provided.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Medicortex Finland

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Medicortex Finland

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Medicortex Finland Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Medicortex Finland

Medicortex Finland operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Banyan Biomarkers, NeuroChaos Solutions, Saccadous, Silver Medical and GLIA Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Develops blood tests for diagnosing traumatic brain injury, advancing medical diagnostics and patient care.
domain founded_year HQ Location
Ultrasound diagnostics for traumatic brain injuries are provided.
domain founded_year HQ Location
Neural disorders are diagnosed and tracked via SaaS eye-movement platform.
domain founded_year HQ Location
Point-of-care diagnostic solutions are developed for sports medicine.
domain founded_year HQ Location
Diagnostic and prognostic tools for brain injuries are manufactured.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Medicortex Finland

Frequently Asked Questions about Medicortex Finland

When was Medicortex Finland founded?

Medicortex Finland was founded in 2014 and raised its 1st funding round 2 years after it was founded.

Where is Medicortex Finland located?

Medicortex Finland is headquartered in Turku, Finland. It is registered at Turku, Varsinais-suomi, Finland.

Is Medicortex Finland a funded company?

Medicortex Finland is a funded company, having raised a total of $581.79K across 5 funding rounds to date. The company's 1st funding round was a Grant of $56.9K, raised on Feb 18, 2016.

What does Medicortex Finland do?

Medicortex Finland was founded in 2014 in Turku, Finland, within the biotechnology sector focused on neurodegenerative diseases. Biomarkers are provided for diagnosing and assessing the severity of brain injuries. Drugs are being developed to halt neuronal degradation resulting from traumatic brain injury or stroke. Operations center on advancing diagnostic accuracy and therapeutic interventions for neurological conditions.

Who are the top competitors of Medicortex Finland?

Medicortex Finland's top competitors include NoMo Diagnostics, NeuroChaos Solutions and GLIA Diagnostics.

What products or services does Medicortex Finland offer?

Medicortex Finland offers TBI Diagnostic Kit and Biomarker R&D Program.

Who are Medicortex Finland's investors?

Medicortex Finland has 5 investors. Key investors include European Union, Business Finland, Dividend Sweden, EIC Fund, and Runar Backstromin Saatio.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available